SAB Biotherapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -2.77 | -100% |
| P/S |
|
1.75 | 33.76 | -94.81% |
|
|
| P/BV |
|
0.0684 | 4.82 | -98.58% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
1.36 | -22.15 | -106.15% |
|
|
| Ev/S |
|
-20.87 | 22.56 | -192.51% |
|
|
| Ev/FCF |
|
1.85 | 68.78 | -97.32% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1533.28 | 4.98 | -30907.73% | -396.81 | +286.4% |
| ROE |
|
-73.64 | 9.61 | -866.13% |
|
|
| ROA |
|
-50.27 | 0.3443 | -14701.15% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-1884.5 | -25.17 | 7387.05% |
|
|
| ROCE |
|
-66.45 | 15.35 | -532.89% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1721 | -3.68 | -95.32% | -0.2934 | -41.36% |
| Nеt Debt/Ebitda |
|
1.48 | -3.44 | -142.94% |
|
|
| Debt/Ratio |
|
0.0704 | 0.1985 | -64.55% |
|
|
| Debt/Equity |
|
0.2535 | 1.66 | -84.75% |
|
|
| Debt/Net Income |
|
-0.14 | 10.32 | -101.36% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-34.15 | -56.89 | -39.97% | ||
| Growth impulse Ebitda in 5 years |
|
364.33 | -54.68 | -766.29% | ||
| Growth impulse Net Income in 5 years |
|
348.87 | -58.33 | -698.1% | ||
| Growth impulse FCF in 5 years |
|
158.33 | -49.48 | -419.99% | ||
| Growth impulse EPS in 5 years |
|
3428.04 | -32.41 | -10677.11% |
IP Score
4.72/10
